Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia

American Journal of Clinical Nutrition

Volumn 80, Issue 4, 2004, Pages 992-997

  De Heijer, Tom ^a   Vermeer, Sarah E ^a   Van Dijk, Ewoud J ^a   Prins, Niels D ^a   Koudstaal, Peter J ^a   Van Duijn, Cornelia M ^a   Hofman, Albert ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alcohol; Alzheimer disease; Amygdala; Brain; Hippocampus; Magnetic resonance imaging

Indexed keywords

APOLIPOPROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN SIZE; DEMENTIA; DRINKING BEHAVIOR; HIPPOCAMPUS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUESTIONNAIRE; WHITE MATTER; AGING; ATROPHY; BRAIN; BRAIN DISEASE; COHORT ANALYSIS; FEMALE; HEALTH SURVEY; HISTOLOGY; MALE; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

AGED; AGED, 80 AND OVER; AGING; ALCOHOL DRINKING; AMYGDALA; ATROPHY; BRAIN; BRAIN DISEASES; CEREBRAL INFARCTION; COHORT STUDIES; DEMENTIA; FEMALE; HEALTH SURVEYS; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 5144222249     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.4.992     Document Type: Article

References (51)

1. Orgogozo JM, Dartigues JF, Lafont S, et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 1997;153:185-92.
2. Ruitenberg A, van Swieten JC, Witteman JCM, et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 2002;359:281-6.
3. Huang W, Qiu C, Winblad B, Fratiglioni L. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J Clin Epidemiol 2002;55:959-64.
4. Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT Jr, Mittleman MA, Siscovick DS. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003;289:1405-13.
5. Hébert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 2000;31:1487-93.
6. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999;319:1523-8.
7. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003;289: 579-88.
8. de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002;33:1152-62.
9. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000;21:321-30.
10. Truelsen T, Thudium D, Grønbæk M. Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 2002;59:1313-9.
11. Henn C, Loffelholz K, Klein J. Stimulatory and inhibitory effects of ethanol on hippocampal acelylcholine release. Naunyn Schmiedebergs Arch Pharmacol 1998;357:640-7.
12. Das UN. Alcohol consumption and risk of dementia. Lancet 2002;360:490 (letter).
13. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta-Analysis Consortium. JAMA 1997;278:1349-56.
14. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-9.
15. Wong TY, Klein R, Sharrett AR, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74.
16. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999;67:66-72.
17. Bobinski M, de Leon MJ, Wegiel J, et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000;95:721-5.
18. Jack CRJ, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-403.
19. Scheltens P, Fox N, Barkhof F, De Carli C. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 2002;1:13-21.
20. Mizuno K, Wakai M, Takeda A, Sobue G. Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: an MRI volumetric and memory assessment study. J Neurol Sci 2000;173:18-24.
21. Killiany RJ, Gomez-Isla T, Moss M, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000;47:430-9.
22. Convit A, de Leon MJ, Tarshish C, et al. Hippocampal volume losses in minimally impaired elderly. Lancet 1995;345:266 (letter).
23. Breteler MMB. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann N Y Acad Sci 2000;903:457-65.
24. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-51.
25. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-22.
26. Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, et al. Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire. Eur J Clin Nutr 1998;52:588-96.
27. Hackert VH, den Heijer T, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MMB. Hippocampal head size associated with verbal memory performance in nondemented elderly. Neuroimage 2002;17:1365-72.
28. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MMB. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002;33:21-5.
29. Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 2001;57:1669-74.
30. Cuenod CA, Denys A, Michot JL, et al. Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol 1993;50:941-5.
31. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-9.
32. Feunekes GI, van 't Veer P, van Staveren WA, Kok FJ. Alcohol intake assessment: the sober facts. Am J Epidemiol 1999;150:105-12.
33. Dufouil C, Ducimetiere P, Alperovitch A. Sex differences in the association between alcohol consumption and cognitive performance. EVA Study Group. Epidemiology of Vascular Aging. Am J Epidemiol 1997;146:405-12.
34. Elias PK, Elias MF, D'Agostino RB, Silbershatz H, Wolf PA. Alcohol consumption and cognitive performance in the Framingham Heart Study. Am J Epidemiol 1999;150:580-9.
35. Kiechl S, Willeit J, Rungger G, Egger G, Oberhollenzer F, Bonora E. Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. Stroke 1998;29:900-7.
36. Mukamal KJ, Longstreth WT Jr, Mittleman MA, Crum RM, Siscovick DS. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the cardiovascular health study. Stroke 2001;32:1939-46.
37. de Leeuw FE, de Groot JC, Bots ML, et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol 2000;247:291-6.
38. Ding J, Eigenbrodt ML, Mosley TH Jr, et al. Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community-based population of middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2004;35:16-21.
39. Bachman DL, Green RC, Benke KS, Cupples LA, Farrer LA. Comparison of Alzheimer's disease risk factors in white and African American families. Neurology 2003;60:1372-4.
40. Tanaka N, Asada T, Kinoshita T, Yamashita F, Uno M. Alcohol consumption and risk of dementia. Lancet 2002;360:491 (letter).
41. Hebert LE, Scherr PA, Beckett LA, et al. Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol 1992;135:347-55.
42. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
43. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003;60:246-52.
44. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MMB. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 2002;59:746-8.
45. Carmelli D, Swan GE, Reed T, Schellenberg GD, Christian JC. The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive function. Neuroepidemiology 1999;18:125-33.
46. Hillbom M. Oxidants, antioxidants, alcohol and stroke. Front Biosci 1999;4:e67-71.
47. Jolivalt C, Leininger-Muller B, Bertrand P, Herber R, Christen Y, Siest G. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic Biol Med 2000;28:129-40.
48. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:8098-102.
49. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neuro-degeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 1993;13:1676-87.
50. Huang HM, Ou HC, Hsieh SJ. Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons. Life Sci 2000;66:1879-92.
51. Dufouil C, Tzourio C, Brayne C, Berr C, Amouyel P, Alpérovitch A. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology 2000;11:280-4.